Nutritional Status Is Superior to the ECOG Performance Status in Predicting the Dose-Intensity of the GEMOX Chemotherapy Regimen in Patients with Advanced Cancer

By Cessot Anatole   Coriat Romain   Mir Oliver   Boudou-Rouquette Pascaline   Giroux Julie   Durand Jean-Philippe   Alexandre Jérôme   Goldwasser Francois  

Nutrition and Cancer, Vol. 65, Iss. 8, 2013-11 ,pp. : 1254-1257

Routledge Ltd

Access to resources Recommend Favorite

Treatment of Elderly Cancer Patients with Chemotherapy

By Wasil Tarun   Lichtman Stuart  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 537-547

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients

By                      

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1094-1100

Spandidos Publications

Access to resources Recommend Favorite

The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer

By Boeck Stefan   Heinemann Volker  

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 41-50

Future Medicine

Access to resources Recommend Favorite

Irinotecan, leucovorin and 5fluorouracil (modified FOLFIRI) as salvage chemotherapy for frail or elderly patients with advanced gastric cancer

By                      

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 751-754

Spandidos Publications

Access to resources Recommend Favorite